Akademik Veri Yönetim Sistemi
European Journal of Pediatrics, cilt.184, sa.1, 2025 (SCI-Expanded)
This study aimed to compare effects of clean intermittent catheterization training, which is routinely applied in hospital, and the Roy Adaptation Model-based, Android phone application (RAMTAKE)-supported clean intermittent catheterization training on caregivers’ knowledge/skill, coping/adaptation levels, and urinary tract infection development in children. The research followed a randomized controlled study approach involving 40 patients and caregivers under clean intermittent catheterization care at a university pediatric nephrology clinic between March 2020 and February 2021. Data were collected from the “sociodemographic questionnaire,” “clean intermittent catheterization application knowledge and skill level assessment form,” and “Coping and Adaptation Processing Scale,” and a urinary tract infection follow-up form was used. Forty caregivers performing clean intermittent catheterization were randomly assigned to the control groups and experimental groups. During the first meeting, data collection tools were applied to both groups as a pre-test. RAMTAKE-supported training was given to the experimental group. After discharge, a home visit, phone call, post-test, and repead test were performed. Routine training was given to the control group in the hospital. The post-test and repead test were applied at the same timepoints as the experimental group. Urine culture tests were performed three times with an interval of 1 month after discharge to the children in both groups. Mann–Whitney U, Wilcoxon, Friedman, and Chi-square tests were used to compare data. Knowledge/skill and coping/adaptation levels of caregivers in experimental group were increased. The incidence of urinary tract infections was decreased in experimental group (p < 0.05). Conclusion: RAMTAKE is effective in increasing the knowledge/skills and coping/adaptation level of caregivers who apply clean intermittent catheterization and decreased of urinary tract infections. Trial registration: ClinicalTrials.gov number: NCT04763382, date: February 2021. (Table presented.)